Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Control Trial to Compare Doxycycline to Isotretinoin for the Treatment of Acneiform Eruptions in Cancer Patients on Tyrosine Kinase Inhibitors

NCT04864717 is registered in ClinicalTrials.gov with Lady Davis Institute as lead sponsor.

NCT NCT04864717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04864717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Control Trial to Compare Doxycycline to Isotretinoin for the Treatment of Acneiform Eruptions in Cancer Patients on Tyrosine Kinase Inhibitors
Lead sponsor
Lady Davis Institute
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2021
Completion date
December 31, 2022
Enrollment
98 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acneiform eruptions, cancer, treatment-related